Table 1 Patient characteristics and summary of treatment efficacy

Gender

F

7

35.0

M

13

65.0

Race

White

16

80.0

Black

4

20.0

Age (years)

Mean

63.40 (10.67)

Median

63 (48–84)

Age (years)

<65

10

50.0

≥65

10

50.0

ECOG performance status

0

2

10

1

13

65

2

5

25

No of prior therapies

1^a

6

30

2^b

6

30

3^c

7

35

4^d

1

5

Best response

PD

15

88.2

SD

2

11.8

Time to progression (TTP)

Mean

6.26 (3.9)

Median

7 (1–17)